Starting Dose of Effexor for a 17-Year-Old
For a 17-year-old, start venlafaxine extended-release (Effexor XR) at 37.5 mg once daily, which can be titrated upward based on response and tolerability.
Dosing Algorithm
The starting dose depends on the indication:
For Anxiety Disorders (GAD, Social Anxiety, Panic Disorder)
- Start: 37.5 mg once daily 1, 2
- Titrate upward in increments of 37.5-75 mg every 4-7 days as tolerated
- Target effective dose: 75-225 mg/day
- Maximum: 225 mg/day
For Major Depressive Disorder
- Start: 37.5 mg once daily 3
- Titrate based on weight and response
- Adolescents (ages 12-17) showed better response than younger children in pooled analyses 3
- Target effective dose: 75-225 mg/day
Critical Safety Considerations
Monitor closely for suicidality, especially in the first weeks of treatment. The FDA black-box warning applies through age 24 4. Venlafaxine may carry greater suicide risk than other SNRIs, and both venlafaxine and desvenlafaxine have been associated with overdose fatalities 4.
Required Monitoring Parameters
- Baseline and ongoing: Height, weight, pulse, blood pressure 4
- Watch for: Treatment-emergent suicidality, behavioral activation, hostility 3
- Common adverse effects: Decreased appetite, weight loss, nausea, somnolence 5, 2
Formulation Matters
Use extended-release (XR) formulation for once-daily dosing. The immediate-release formulation has a short half-life requiring 2-3 times daily dosing and is associated with more discontinuation symptoms 4.
Evidence-Based Considerations
While venlafaxine showed efficacy in pediatric anxiety disorders 1, 2, the FDA has not established its safety and efficacy in pediatric patients for depression 3. Duloxetine is the only SNRI with FDA approval for pediatric anxiety (GAD in ages ≥7 years) 4.
Weight and Growth Concerns
In 8-16 week trials, pediatric patients on venlafaxine XR lost an average of 0.45-0.75 kg while placebo patients gained weight 5. Height increases were also less than expected, particularly in children under 12 5. This warrants careful monitoring during treatment.
Discontinuation
Never stop abruptly. Venlafaxine is particularly associated with discontinuation syndrome 4. Always taper slowly when discontinuing.
Practical Prescribing
The 37.5 mg starting dose balances tolerability with the need to reach therapeutic levels. Most adolescents in clinical trials required doses of 75 mg/day or higher for efficacy 1, 2, but starting lower reduces initial adverse effects like nausea and allows assessment of tolerability before escalation.